课题基金 / 基金详情

Integrative Curation of Clinically Relevant Variants in X-Linked Inherited Retinal Disease Genes

Integrative Curation of Clinically Relevant Variants in X-Linked Inherited Retinal Disease Genes
X连锁遗传性视网膜疾病基因临床相关变异的综合治疗
批准号:
10413460
负责人:
KIM C WORLEY
金额:
$35.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-01 至 2025-05-31

项目摘要

项目成果

KIM C WORLEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Inherited retinal diseases (IRD) are a major cause of early-onset blindness, profoundly affecting millions of patients. Given the clinical and genetic heterogeneity of IRD, targeted gene therapy is emerging as the main effective approach for treating the disease with many clinical trials currently underway. To maximize the benefit of these emerging therapies to patients, molecular diagnosis is the first critical step. In coordinating with the ClinGen Ocular Clinical Domain Working Group committee, we propose to establish a new variant curation expert panel (VCEP) that will focus on developing disease and gene specifications and curating expert assessment of variants in the seven X-linked IRD genes, including RPGR, CHM, RS1, RP2, OFD1, NDP, and CACNA1F. Collectively, mutations in these genes account for 15% of IRD patients. We have identified a distinguished panel of scientists across the world who will commit to this effort with diverse expertise: practicing ophthalmologic physicians, clinical diagnostic laboratory directors, and world-leading researchers studying the function of the X-linked IRD genes in the clinical and research domains. These experts bring complementary knowledge and resources to this effort including functional laboratory assays to assess the impact of patient variants, clinical trials for gene-based treatments, and collections of patient samples with sequenced variants and a detailed clinical history. Together with dedicated bioinformatics, curatorial, and administrative support, the X-linked IRD Variant Curation Panel proposed will deploy the FDA approved ClinGen infrastructure tools and processes in combination with the supportive resources we propose to collect, organize and provide to the panel to develop rule specifications for X-linked IRD gene curation. With our panel and team of coordinated curation volunteers, we will curate and expertly assess the variants in these genes. The products of this effort will be two-fold. First, specifications that can be applied to assess new variants in the seven genes and can be adapted for other X-linked IRD genes. And second, curated variants in the seven X-linked IRD genes with three-star (expert panel assessed) ratings in the ClinVar databasethat will improve the assessment of de novo patient variants and enable treatments with gene-based therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integrative Curation of Clinically Relevant Variants in X-Linked Inherited Retinal Disease Genes
  • 批准号:
    10661508
  • 项目类别:
  • 资助金额:
    $34.37万
  • 财政年份:
    2022
  • 负责人:
    KIM C WORLEY
  • 依托单位:
RETINA SPECIFIC TRANSCRIPT MAP OF THE HUMAN GENOME
  • 批准号:
    6179281
  • 项目类别:
  • 资助金额:
    $24.03万
  • 财政年份:
    1999
  • 负责人:
    KIM C WORLEY
  • 依托单位:
RETINA SPECIFIC TRANSCRIPT MAP OF THE HUMAN GENOME
  • 批准号:
    6384825
  • 项目类别:
  • 资助金额:
    $24.72万
  • 财政年份:
    1999
  • 负责人:
    KIM C WORLEY
  • 依托单位:
RETINA SPECIFIC TRANSCRIPT MAP OF THE HUMAN GENOME
  • 批准号:
    2883923
  • 项目类别:
  • 资助金额:
    $24.77万
  • 财政年份:
    1999
  • 负责人:
    KIM C WORLEY
  • 依托单位:
海外基金